| First US patient treated with Medtronic’s FDA-approved renal denervation system |
| ‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful |
| Johnson & Johnson acquires medical device company behind new LAA technology for $400M |
| Cardiologist receives $7M for 5-year study to boost care for heart failure patients |
| Avidity Biosciences inks drug discovery deal worth up to $2.3B with industry heavyweight |
| Robotic-assisted CABG reduces healthcare costs, primarily thanks to shorter hospital stays |
| New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months |
| Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR? |
| Medtronic debuts new FDA-cleared LAA exclusion device |
| FDA announces recall of infusion sets due to defect that puts diabetes patients at risk |
| Mediterranean diet improves cardiovascular health of middle-aged women |
| Bayer ends blood thinner trial early due to lack of efficacy |
| ADHD medications associated with heightened CVD risk |
| Sensitivity to dairy products, other foods linked to higher risk of death from heart disease |
| Medtronic gains 2 key approvals for its ablation portfolio |
| Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists |
| Smartphone app helps TAVR patients avoid major complications |
| FDA clears AI-powered image reconstruction technology for cardiac CT scanners |
| FDA approves another renal denervation system for hypertension |
| Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades |
| Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR |
| Daily marijuana use increases heart failure risk by 34% |
| ChatGPT struggles with echocardiography, but still shows potential to help cardiology trainees |
| The expanding scope of FDG-PET in nuclear cardiac imaging |
| CVD deaths have increased dramatically, undoing years of progress |
| TAVR linked to favorable outcomes for asymptomatic and minimally symptomatic patients—but is it necessary? |
| Cardiologist reprimanded for performing surgery after testing positive for COVID-19 |
| A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes |
| Fully bioresorbable stents boost care for CLI patients in LIFE-BTK trial |
| The future of cardiology: 5 potentially game-changing AI studies from AHA 2023 |
| PCI benefits patients with stable chest pain, late-breaking data confirm |
| Shockwave C²⁺ Now Available in the U.S. |
| 10 ways to improve care for in-hospital cardiac arrest |
| Intrepid transfemoral transcatheter mitral valve shows favorable results after 1 year |
| TAVR utilization skyrocketed over 5-year period, improving survival for older AS patients |
| Cardiologists develop new way to evaluate heart risks—kidney function, metabolic health included for first time |
| AI specialists raise $80M to ramp up commercialization of imaging analysis software |
| Ross procedure still linked to ‘excellent’ outcomes as patients enter third decade after surgery |
| PHOTO GALLERY: Interventional cardiology technologies at TCT 2023 |
| Cardiologist arrested in undercover operation targeting sex predators |
| FDA approves diabetes drug tirzepatide for chronic weight management under new name |
| iFR and FFR are equal, new long-term analysis confirms |
| CMS increases reimbursement for AI-powered heart failure platform |
| FDA approves first renal denervation system for uncontrolled hypertension |
| American Heart Association ‘enthusiastically’ joins other cardiology groups in push for new, independent medical board |
| ChatGPT tackles hypertension: Popular AI model a helpful resource for patients with high blood pressure |
| FDA announces Class I recall of nearly 2,000 catheter kits |
| AI model for predicting sudden cardiac death more accurate than expected |
| Private equity-backed pharmaceutical company acquires stroke drug from Bayer |
| Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients |
| Key trends in transcatheter tricuspid and mitral valve technologies |
| TAVR or SAVR? Where things stand now, from a surgeon's perspective |
| CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure |
| Cardiologists, heart surgeons and imaging experts push for changes that could prevent ‘permanent and unjustifiable Medicare cuts’ |
| Next-gen RF catheter from Biosense Webster improves QOL in patients with paroxysmal AFib |
| IVUS-guided PCI boosts 2-year survival, reduces need for bypass surgery |
| TAVR and LAAO at the same time? Samir Kapadia breaks down the WATCH-TAVR trial |
| FDA grants breakthrough device designation to AI-powered, retinal imaging-based CVD assessments |
| TAVR patients with cancer face higher risks of hospital readmission, serious bleeding |
| Second patient in history to receive a pig heart transplant dies after 6 weeks |
| IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades |
